Table 2.
Agent | Drug class | Stage of development in breast cancer |
Nanoparticle albumin-bound (nab-) paclitaxel | Taxane | Approved |
Larotaxel | Taxane | III |
Ixabepilone | Epothilone | Approved |
Patupilone | Epothilone | II |
ZK-EPO | Epothilone | II |
BMS-310705 | Epothilone | I |
KOS-862 | Epothilone | Discontinued |
Vinflunine | Vinca alkaloid | II |
Eribulin | Mitotic inhibitor | III |
Trabectedin | Nucleotide excision repair inhibitor, cell cycle inhibitor | III |